Ciclopirox, an antifungal medicated nail solution, is being discontinued (pharmacode 2401797).
Why are we doing this?
Ciclopirox is currently supplied by Apotex. Apotex is leaving the New Zealand market. To date, we have been unable to find an alternative supplier for ciclopirox. We are still looking for a long-term supplier of ciclopirox.
We have received clinical advice that amorolfine nail solution 5% (MycoNail) is a suitable funded alternative for most people (pharmacode 2461633).
Amorolfine is fully funded without restriction.
End November 2021: Stock of Apo-Ciclopirox is expected to run out.
1 May 2022: Apo-Ciclopirox will be delisted.
Who to contact
If you are using ciclopirox, talk to your pharmacist or the person who prescribed the ciclopirox. They are in the best place to advise on your clinical circumstances.
If you have funding questions about ciclopirox, email email@example.com